|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 23, 2017 ) Latin America Liquid Biopsy market is expected to increase at a CAGR of 27.6% in the forecast period of 2016-2021 and reach a value of USD 319.43 million by 2021 from USD 94.43 million in 2016.
For full report refer to http://www.marketdataforecast.com/market-reports/latin-america-liquid-biopsy-market-954/
Free sample of the report is available at http://www.marketdataforecast.com/market-reports/latin-america-liquid-biopsy-market-954/request-sample
Liquid Biopsies are much more favourable for patients because it doesn't have the potential risks of traditional biopsies. The technique involves using "microwells" to grow clusters of tumour cells from a patient's blood sample. This procedure could give feedback as quickly as two weeks after treatment has begun. Liquid biopsy provides crucial information about the treatment taken by a patient which helps the doctors to identify whether a patient's cancer is responsive or resistant to a drug and then make a switch if needed. This is a key driving force for the use of liquid biopsy as this advancement was not provided by tissue biopsies. Lack of documented evidence about the efficacy of the process is the factor hindering the growth of liquid biopsy market.
Latin American liquid biopsy market is mainly segmented by types of cancer into Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. By Diagnostic approach they can be classified as Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end users, the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users. The market is bifurcate into blood, urine, plasma, saliva and Cerebrospinal fluid based upon sample type. CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.
Enquire more about the report http://www.marketdataforecast.com/market-reports/latin-america-liquid-biopsy-market-954/inquire
The Liquid Biopsy Market is segmented as follows:
By Cancer Type:
Lung Cancer
Pancreatic Cancer
Leukaemia
Other Visceral Cancers
By Sample Type:
Blood
Urine
Plasma
Saliva
Cerebrospinal
By Diagnostic Approach:
Circulating Tumour cells (CTC)
Circulating Tumour DNA (ctDNA)
RNA in exosomes
Extra-Cellular Vesicles
By End Users:
Reference Laboratories
Hospital/Physician Laboratories
Academic and Research Centers
Other End Users
By Geography
Mexico
Brazil
Argentina
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Buy now https://www.marketdataforecast.com/cart/buy-now/latin-america-liquid-biopsy-market-954
The Liquid Biopsy Market study offers the following deliverables:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development.
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout related reports in the Diagnostic Category:
Latin America Acute Ischemic Stroke Diagnosis and Treatment Market: http://www.marketdataforecast.com/market-reports/latin-america-acute-ischemic-stroke-diagnosis-market-269/
Latin America Autoimmune Diagnostics Market: http://www.marketdataforecast.com/market-reports/latin-america-autoimmune-diagnostics-market-1194/
Latin America Blood Testing Market: http://www.marketdataforecast.com/market-reports/latin-america-blood-testing-market-1409/
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
